Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma
CA 2058178 A1 · Owner: Merck Sharp & Dohme Limited · Inventors: Showell, Graham A.; Lotti, Victor
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A class of pyrazine, pyrimidine and pyridazine derivatives, substituted by a non-aromatic azabicyclic ring system and optionally by up to two further substituents, is of use in the preparation of medicaments, especially formulations adapted for topical administration to the eye, suitable for the treatment of glaucoma and/or for reducing intraocular pressure.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 20, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 20, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 20, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.